Mobile

A European Multicenter Open-label Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients

Update Il y a 4 ans
Reference: EUCTR2008-001841-24

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

The primary objective of the study is to compare the percentage of patients reaching an effective fentanyl buccal tablet (FBT) dose with a starting dose of 100 mcg (Group A) to those with a starting dose of 200 mcg (Group B).

Inclusion criteria

  • Breakthrough Pain (BTP) in cancer patients

Links